GOG-3119 MK-2870-033 TroFuse-033 sac-TMT + Pembro as 1L Maintenance in pMMr Endometrial cancer - Clinical Trial

Adultos

A Phase 3 Randomized, Open-label, Multicenter Study to Compare the Efficacy and safety of Sacituzumab Tirumotecan in Combination with Pembrolizumab Versus Pembrolizumab Alone as First-line Maintenance Treatment in Participants with Mismatch Repair Proficient Endometrial Cancer (TroFuse-033/GOG-3119/ENGOT-en29)